Home Medicine Risk factors for fetal-to-maternal transfusion in Rh D-negative women – results of a prospective study on 942 pregnant women
Article
Licensed
Unlicensed Requires Authentication

Risk factors for fetal-to-maternal transfusion in Rh D-negative women – results of a prospective study on 942 pregnant women

  • M. David , J. Smidt , F.C.K. Chen , U. Stein and J.W. Dudenhausen
Published/Copyright: June 1, 2005
Journal of Perinatal Medicine
From the journal Volume 32 Issue 3

Abstract

Aims: To investigate the incidence of severe fetal-to-maternal transfusion after delivery and to identify risk factors.

Material and methods: In a prospective study at the Department of Obstetrics, Charité, Campus Virchow- Klinikum, Berlin, Germany, we analyzed the incidence of severe fetal-to-maternal transfusion (>10 ml) and fetalto- maternal hemorrhage (>25 ml) in Rh D-negative pregnant women after delivery of Rh D-positive infants. 942 women were included in the study and Kleihauer-Betke tests were performed. The results were compared to perinatal data.

Results: Fetal-to-maternal hemorrhage occurred in 13 cases out of 942 (incidence of 1.3%) and severe fetalto- maternal transfusion in 61 cases (6.5%). In all of the cases with fetal-to-maternal hemorrhage, mothers were compatible with their infants in ABO-system. The incidence of fetal-to-maternal transfusion and its severe form was significantly higher in twin pregnancies (7/21 cases and 5/21 cases respectively, 33.3% and 23.8%) than in singleton pregnancies (22.5% and 5.9%, P<0.001). All other factors, such as maternal age, parity, ethnicity, mode of delivery, presentation, duration of first and second stage of labor, CTG, or Apgar score were not associated with an increased risk of severe fetal-to maternal transfusion.

Conclusions: Twin pregnancy is the only independent risk factor for severe fetal-to-maternal transfusion. ABO-incompatibility between mother and infant seems to be protective against Rh D-alloimmunization.

:
Published Online: 2005-06-01
Published in Print: 2004-05-05

Copyright © 2004 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Second overview of relationships between antenatalpharmacologic magnesium sulfate and neurologic outcomes in children
  2. Prevention of toxoplasmosis during pregnancy – an epidemiologic survey over 22 consecutive years
  3. The impact of multiple pregnancies and malformations on perinatal mortality
  4. Oral nifedipine maintenance therapy after acute intravenous tocolysis in preterm labor
  5. Perinatal outcome in women with severe pregnancy complications and multiple thrombophilias
  6. Reproducibility of the study of placental vascularization by three-dimensional power Doppler
  7. The prevalence of preterm deliveries in Berlin has not changed over 7 years: the impact of multiple births
  8. Amniotic fluid and cord plasma erythropoietin levels in pregnancies complicated by preeclampsia, pregnancy-induced hypertension and chronic hypertension
  9. N-Glycans of human amniotic fluid transferrin stimulate progesterone production in human first trimester trophoblast cells in vitro
  10. Risk factors for fetal-to-maternal transfusion in Rh D-negative women – results of a prospective study on 942 pregnant women
  11. Does fetal head position at the term plus 12 scan influence induction, labor and delivery outcome?
  12. Doppler examinations of fetal and uteroplacental blood flow in AGA and IUGR fetuses before and after maternal physical exercise with the bicycle ergometer
  13. Maternal serum, amniotic fluid and cord leptin levels at term: their correlations with fetal weight
  14. Intrauterine smoke exposure: a new risk factor for bronchopulmonary dysplasia?
  15. Effect of Phenobarbital on free radicals in neonates with hypoxic ischemic encephalopathy – a randomized controlled trial
  16. Increase in cord blood soluble E-selectin and tracheal aspirate neutrophils at birth and the development of new bronchopulmonary dysplasia
  17. Biliary atresia due to delayed maturation of the gut hormones system? – Introducing a new treatment modality
Downloaded on 31.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/JPM.2004.047/html
Scroll to top button